GSK-3 Inhibitor Promotes Neuronal Cell Regeneration and Functional Recovery in a Rat Model of Spinal Cord Injury

Abstract EN

The reparative process following spinal cord injury (SCI) is extremely complicated.

Cells in the microenvironment express multiple inhibitory factors that affect axonal regeneration over a prolonged period of time.

The axon growth inhibitory factor glycogen synthase kinase-3 (GSK-3) is an important factor during these processes.

TDZD-8 (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) is the most effective and specific non-ATP-competitive inhibitor of GSK-3.

Here, we show that administering TDZD-8 after SCI was associated with significantly inhibited neuronal apoptosis, upregulated GAP-43 expression, increased density of cortical spinal tract fibers around areas of injury, and increased Basso, Beattie, and Bresnahan (BBB) scores in the lower limbs.

These findings support the notion that GSK-3 inhibitors promote neuronal cell regeneration and lower limb functional recovery.